Internal Medicine, Cardiovascular Disease · Visalia, CA
NPI
1346270113
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
5120 W Cypress Ave
Visalia, CA, 93277
Phone (559) 635-4800
Groups this clinician bills Medicare through
Medicare paid, 2024
$472K
6,032 services
Medicare patients, 2024
1,223
Average age 75
Drug cost, 2024
$888K
4,316 prescriptions
Company payments, 2025
$1,666
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sukhvinder Bhajal was code 99214 (office e&m - established), 2,338 times for 1,051 patients. In total Sukhvinder Bhajal billed 6,032 services in 60 codes, and Medicare paid $472K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-06-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 2,338 | 1,051 | $85.89 | $201K |
| 93000 Electrocardiogram | Office | 1,969 | 978 | $9.91 | $20K |
| 93306 Echocardiography (TTE/TEE) | Office | 501 | 500 | $134.67 | $67K |
| 99204 Office E&M - New | Office | 181 | 181 | $112.40 | $20K |
| 93284 External Electrocardiographic Monitoring | Office | 128 | 77 | $72.92 | $9,334 |
| 93280 External Electrocardiographic Monitoring | Office | 120 | 90 | $55.42 | $6,651 |
| 93656 Comprehensive Electrophysiologic Evaluation | Facility | 65 | 64 | $633.47 | $41K |
| 93282 External Electrocardiographic Monitoring | Office | 65 | 48 | $50.03 | $3,252 |
| 99232 Hospital E&M - Subsequent | Facility | 63 | 47 | $56.07 | $3,532 |
| 99223 Hospital E&M - Initial | Facility | 57 | 57 | $122.85 | $7,003 |
| 93281 External Electrocardiographic Monitoring | Office | 52 | 36 | $54.92 | $2,856 |
| 93283 External Electrocardiographic Monitoring | Office | 49 | 31 | $67.93 | $3,329 |
| 33249 Insertion/Removal/Replacement ICD | Facility | 44 | 44 | $611.02 | $27K |
| 93306 Echocardiography (TTE/TEE) | Facility | 36 | 36 | $49.07 | $1,767 |
| 93291 External Electrocardiographic Monitoring | Office | 28 | 23 | $35.52 | $995 |
By year: 2022 $441K for 5,371 services; 2023 $452K for 5,601 services; 2024 $472K for 6,032 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sukhvinder Bhajal prescribed most often to Medicare patients was Flecainide Acetate, with 670 prescriptions and refills. In total Sukhvinder Bhajal wrote 4,316 Medicare prescriptions that cost $888K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Flecainide Acetate Generic | 670 | 1,510 | 181 | $34K |
| Eliquis Apixaban | 639 | 972 | 144 | $551K |
| Losartan Potassium Generic | 324 | 769 | 88 | $2,100 |
| Hydrochlorothiazide Generic | 259 | 545 | 64 | $575 |
| Furosemide Generic | 233 | 477 | 71 | $1,190 |
| Amiodarone Hcl Generic | 220 | 456 | 59 | $2,474 |
| Metoprolol Tartrate Generic | 192 | 438 | 60 | $1,056 |
| Carvedilol Generic | 144 | 352 | 47 | $818 |
| Amlodipine Besylate Generic | 143 | 341 | 41 | $426 |
| Metoprolol Succinate Generic | 141 | 330 | 40 | $1,397 |
| Atorvastatin Calcium Generic | 130 | 343 | 42 | $936 |
| Xarelto Rivaroxaban | 116 | 236 | 33 | $129K |
| Diltiazem Hcl Generic | 108 | 215 | 34 | $2,037 |
| Spironolactone Generic | 100 | 218 | 29 | $663 |
| Lisinopril Generic | 86 | 230 | 26 | $607 |
Brand drugs: 983 claims; generic drugs: 3,333 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sukhvinder Bhajal $1,666 ($1,666 in general payments such as food, travel and fees) from 5 companies. The largest payer was Medtronic, Inc. with $701.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.